Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer

Author： Buzdar Aman   Chlebowski Rowan   Cuzick Jack   Duffy Sean   Forbes John   Jonat Walter   Ravdin Peter    

Publisher： Informa Healthcare

E-ISSN： 0300-7995|22|8|1575-1585

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.22, Iss.8, 2006-08, pp. : 1575-1585

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer

By Ligibel Jennifer A   Winer Eric P  

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 89-97

Future Medicine

Access to resources Recommend Favorite

Adjuvant Endocrine Treatment in Premenopausal Early Breast Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 9-13

Karger

Access to resources Recommend Favorite

The Emerging Role of Aromatase Inhibitors in the Adjuvant Management of Breast Cancer

By  

Reviews on Recent Clinical Trials, Vol. 1, Iss. 3, 2006-09 ,pp. : 237-249

Bentham Science Publishers

Access to resources Recommend Favorite

Eligibility, Compliance and Persistence of Sequential Therapy with Aromatase Inhibitors following 2–3 Years of Tamoxifen in Endocrine Adjuvant Breast Cancer Therapy

By  

Oncology, Vol. 81, Iss. 3-4, 2011-10 ,pp. : 151-157

Karger

Access to resources Recommend Favorite

Optimal Treatment Strategies in Hormone-Responsive Early Breast Cancer: The Role of Aromatase Inhibitors

By  

Oncology Research and Treatment, Vol. 30, Iss. 1-2, 2007-01 ,pp. : 55-64

Karger

Access to resources Recommend Favorite